Loading...

FDA Approves Additional COVID Vaccine Dose for Some Individuals

August 13, 2021 by TWN Staff
A vial of the Pfizer COVID-19 vaccine. (Photo by Dan McCue)

The Food and Drug Administration has authorized the use of an additional dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines for organ transplant recipients diagnosed as immunocompromised.

Thursday’s announcement came ahead of a meeting today of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices.

At that meeting, the advisory panel voted 11-0 to endorse giving third doses of mRNA vaccines to people with moderately to severely weakened immune systems.

“The country has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease,” said Acting FDA Commissioner Janet Woodcock, M.D. in a written statement. “After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna vaccines.” 

Woodcock went on to say Thursday’s action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID-19. 

“As we’ve previously stated, other individuals who are fully vaccinated are adequately protected and do not need an additional dose of COVID-19 vaccine at this time. The FDA is actively engaged in a science-based, rigorous process with our federal partners to consider whether an additional dose may be needed in the future,” Woodcock said.

People who are immunocompromised in a manner similar to those who have undergone solid organ transplantation have a reduced ability to fight infections and other diseases, and they are especially vulnerable to infections, including COVID-19. 

The FDA evaluated information on the use of a third dose of the Pfizer-BioNTech or Moderna vaccines in these individuals and determined that the administration of third vaccine doses may increase protection in this population. These patients should be counseled to maintain physical precautions to help prevent COVID-19. 

In addition, close contacts of immunocompromised persons should get vaccinated, as appropriate for their health status, to provide increased protection to their loved ones.

The Pfizer-BioNTech COVID-19 vaccine is currently authorized for emergency use in individuals ages 12 and older, and the Moderna COVID-19 vaccine is authorized for emergency use in individuals ages 18 and older. 

Both vaccines are administered as a series of two shots: the Pfizer-BioNTech vaccine shots are administered three weeks apart, and the Moderna vaccine shots are administered one month apart. 

The authorizations for these vaccines have been amended to allow for an additional, or third, dose to be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.

In The News

Health

Voting

Health

Anti-Abortion Activists Aim to Sway GOP White House Hopefuls

CHICAGO (AP) — Emboldened anti-abortion activists are looking to the 2024 presidential election as an opportunity to solidify their influence over the... Read More

CHICAGO (AP) — Emboldened anti-abortion activists are looking to the 2024 presidential election as an opportunity to solidify their influence over the Republican Party. Susan B. Anthony Pro-Life America, the most influential group in the anti-abortion movement, is telling each potential GOP presidential hopeful that to win its... Read More

February 1, 2023
by Eden Metzger
Hawaii Senator Seeks to Crack Down on Sex Traffickers

HONOLULU — Sen. Mazie Hirono, D-Hawaii, is continuing to press law enforcement and other officials to stem the rising tide... Read More

HONOLULU — Sen. Mazie Hirono, D-Hawaii, is continuing to press law enforcement and other officials to stem the rising tide of gender-based violence and sex-trafficking involving Native Hawaiian women and girls. Recently she traveled back to the big island from Washington for discussion on the issue... Read More

January 31, 2023
by TWN Staff
Marburg Vaccine Shows Promising Results in First-In-Human Study

WASHINGTON — An experimental vaccine against Marburg virus, a member of the Ebola virus family that causes death in a... Read More

WASHINGTON — An experimental vaccine against Marburg virus, a member of the Ebola virus family that causes death in a large proportion of infected individuals, proved safe and induced an immune response in a small, first-in-human clinical trial. The findings of the researchers at the National... Read More

January 31, 2023
by Dan McCue
CMS Seeking to Claw Back Improper Medicare Advantage Payments

WASHINGTON — The federal government will begin auditing Medicare Advantage insurers under a new rule finalized Monday, the heightened scrutiny... Read More

WASHINGTON — The federal government will begin auditing Medicare Advantage insurers under a new rule finalized Monday, the heightened scrutiny expected to return as much as $4.7 billion to Medicare’s trust fund over the next 10 years. Watchdog groups had long complained about questionable charges to... Read More

January 31, 2023
by Dan McCue
Administration Moves to Expand Birth Control Coverage Under ACA

WASHINGTON — Women whose employers opted out of covering contraceptives under their health insurance plans on religious grounds could regain... Read More

WASHINGTON — Women whose employers opted out of covering contraceptives under their health insurance plans on religious grounds could regain no-cost access to birth control under new rules proposed by the Biden administration. If implemented, the rules, which were announced under the auspices of the Departments... Read More

January 31, 2023
by Dan McCue
White House Preparing to End COVID-19 Emergencies in May

WASHINGTON — The White House said Monday that President Biden will end dual national emergencies declared to deal with the... Read More

WASHINGTON — The White House said Monday that President Biden will end dual national emergencies declared to deal with the COVID-19 public health crisis in May, nearly three years after they were first declared. The announcement came 24 hours before the Republican-controlled House was to vote... Read More

News From The Well